Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Bone Marrow Transplantation
|
December 14, 2004
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications
D W Beelen, R Trenschel, J Casper, et al.
Leukemia
|
November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease
R Arnold, G Massenkeil, M Bornhäuser, et al.
Bone Marrow Transplantation
|
June 11, 2003
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor
H G Sayer, M Kröger, J Beyer, et al.
Bone Marrow Transplantation
|
February 9, 2016
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas
F Heinzelmann, W Bethge, D W Beelen, et al.
Bone Marrow Transplantation
|
February 21, 2007
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma
M Schmidt-Hieber, I W Blau, R Trenschel, et al.
Bone Marrow Transplantation
|
December 14, 2011
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning
J Casper, J Holowiecki, R Trenschel, et al.
Bone Marrow Transplantation
|
July 1, 1997
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells
H D Ottinger, E Albert, R Arnold, et al.
Annals of Hematology
|
January 18, 2002
Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells
H D Ottinger, C R Müller, S F Goldmann, et al.
Leukemia
|
August 15, 2017
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
R Hehlmann, M Lauseker, S Saußele, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Bone Marrow Transplantation
|
December 14, 2004
Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications
D W Beelen, R Trenschel, J Casper, et al.
Leukemia
|
November 28, 2002
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease
R Arnold, G Massenkeil, M Bornhäuser, et al.
Bone Marrow Transplantation
|
June 11, 2003
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor
H G Sayer, M Kröger, J Beyer, et al.
Bone Marrow Transplantation
|
February 9, 2016
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas
F Heinzelmann, W Bethge, D W Beelen, et al.
Bone Marrow Transplantation
|
February 21, 2007
Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma
M Schmidt-Hieber, I W Blau, R Trenschel, et al.
Bone Marrow Transplantation
|
December 14, 2011
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning
J Casper, J Holowiecki, R Trenschel, et al.
Bone Marrow Transplantation
|
July 1, 1997
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells
H D Ottinger, E Albert, R Arnold, et al.
Annals of Hematology
|
January 18, 2002
Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells
H D Ottinger, C R Müller, S F Goldmann, et al.
Leukemia
|
August 15, 2017
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
R Hehlmann, M Lauseker, S Saußele, et al.
Page
of 10